Publications by authors named "Eric Lowe"

Claim this Profile
A
Advances and updates in pediatric anaplastic large cell lymphoma.
Lianna J Marks, Eric Lowe, Kala Kamdar

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic large cell lymphoma in children and adolescents.
Eric J Lowe, Wilhelm Woessmann

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of novel multi-client inhibitors of Sec61 with broad antitumor activity.
Eric Lowe, Janet L Anderl, David Bade, Cristina Delgado-Martin, Chengguo Dong

J Pharmacol Exp Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyzing the CBC for common pediatric hematologic disorders in primary care.
Charlotte McCrary, Eric J Lowe

Curr Probl Pediatr Adolesc Health Care· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.
Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers, Eric J Lowe

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing EPR pulses for broadband excitation and refocusing.
Eric R Lowe, Stefan Stoll, J P Kestner

J Magn Reson· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
Eric Lowe, Yael P Mossé

Oncol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal peptide mimicry primes Sec61 for client-selective inhibition.
Shahid Rehan, Dale Tranter, Phillip P Sharp, Gregory B Craven, Eric Lowe

Nat Chem Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
Nader Kim El-Mallawany, Sarah Alexander, Mark Fluchel, Robert J Hayashi, Eric J Lowe

Pediatr Blood Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
Jennifer E Agrusa, Emily R Egress, Eric J Lowe

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1.
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.
Yaya Chu, Aliza Gardenswartz, Caroline Diorio, Lianna J Marks, Eric Lowe

Best Pract Res Clin Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses.
Tony Muchamuel, R Andrea Fan, Janet L Anderl, Darrin J Bomba, Henry W B Johnson, Eric Lowe

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK inhibitors for ALK-altered paediatric malignancies.
Laurence Brugieres, Zeinab Afify, Eric Lowe

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Andrew D J Pearson, Elly Barry, Yael P Mossé, Franca Ligas, Nick Bird, Eric Lowe

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1.
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK.
Hugo Larose, G A Amos Burke, Eric J Lowe, Suzanne D Turner

Br J Haematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Remission of Monosomy 7 Six Years After Diagnosis.
Holly J Edington, Eric J Lowe

J Pediatr Hematol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).
Henry W B Johnson, Eric Lowe, Janet L Anderl, Andrea Fan, Tony Muchamuel

J Med Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.
Henry W B Johnson, Janet L Anderl, Erin K Bradley, John Bui, Jeffrey Jones, Eric Lowe

ACS Med Chem Lett· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells.
Joel D Federspiel, Simona G Codreanu, Sandeep Goyal, Matthew E Albertolle, Eric Lowe

Mol Cell Proteomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoma-like Posttransplant Lymphoproliferative Disorder in a Pediatric Heart Transplant Recipient.
Sara Rhodes Proctor Short, Steven L Cook, Andrew S Kim, Jacqueline M Lamour, Eric J Lowe

J Pediatr Hematol Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Sarah Alexander, Jacqueline M Kraveka, Sheila Weitzman, Eric Lowe, Lynette Smith

Pediatr Blood Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhyloSift: phylogenetic analysis of genomes and metagenomes.
Aaron E Darling, Guillaume Jospin, Eric Lowe, Frederick A Matsen, Holly M Bik

PeerJ· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic large cell lymphoma in children and adolescents.
Eric J Lowe, Thomas G Gross

Pediatr Hematol Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis